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ABSTRACT
Objective: Osteoporosis is the most common disease worldwide; nutritional factors may play a significant role in the progression of the disease. The 
aim of this study was to assess the various biochemical parameters in the postmenopausal women with osteoporosis or osteopenia.
Methods: In this hospital-based study, total 70 postmenopausal women, 45-80 years of age group, were studied. They were categorized into two groups 
as Case I and Case II on the basis of diagnosis of osteoporosis and osteopenia, respectively. The bone mineral density using T-score was estimated for 
diagnosis of osteoporosis or osteopenia. Bone mineral markers, i.e., total calcium and ionized calcium (CAI) were estimated by colorimetric method. 
Serum phosphate was estimated by direct method, and alkaline phosphatase (ALP) was measured by kinetic method. Biochemical parameters, 
i.e., urea, were estimated by diacetyl monoxime method. Serum albumin and serum creatinine were measured by bromocresol green method and 
Jaffe’s method, respectively. Serum uric acid and magnesium were estimated by colorimetric method.
Results: Total calcium and CAI were significant (<0.05) between the groups. The levels of serum phosphate and ALP were higher in osteoporotic 
group, but the results were not significant between the groups. Serum urea and serum albumin were comparatively higher and lower in osteoporotic 
group, respectively, but the findings were not significant between the groups. The significant results of serum creatinine, serum uric acid, and serum 
magnesium were obtained while comparing between osteoporotic patients and osteopenia patients. The levels were higher in osteoporosis group. 
There was a negative association of ALP with serum calcium and negative association with serum phosphate and uric acid.
Conclusion: Biochemical alterations are characterized in osteoporotic as well as osteopenic patients. Monitoring of these parameters may be 
beneficial while giving the treatment to these patients for the prevention of other life-threatening risks.
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INTRODUCTION
Osteoporosis is the most frequently occurred disease worldwide and 
has become a public health problem [1]. Osteoporosis is quite common 
in women compared to men, especially in the elderly population. 
Osteoporosis, a metabolic skeletal disease, characterized by the 
microarchitectural deterioration of bone tissue, leading to increased 
bone fragility and resulting in increased risk of fracture [2]. It is mainly 
due to the prime deficiency of calcium, as low dietary intake of calcium 
leads to risk of fractures in later stages [3], and vitamin D, which plays 
an important role calcium absorption and osteoclastic activity [4]. 
Factors such as poor vision, inadequate physical activity, aging, frequent 
falls, low body weight, hormonal changes, poor health, and personal 
history of fractures may also be associated with osteoporosis [5]. 
Estrogen plays a fundamental role in skeletal growth, and bone 
homeostasis and its deficiency make prominence of osteoporosis in 
postmenopausal women [6]. Nutritional factors play significant role in 
the body, may be associated with progression of osteoporosis, so the 
evaluation of other biochemical markers might be useful for avoiding 
the other life-threatening diseases. Protein malnutrition predisposes to 
fall and diminish the soft tissue cover over bone prominence; albumin 
may be the best predictor in osteoporosis [7]. Alkaline phosphatase 
(ALP), an enzyme found in liver, bone, kidneys, and placenta, is an 
indicator of osteoblastic activity [8]. Magnesium, an important cation 
for various metabolic processes [9], has an existing association with 
bone loss [10] due to approximately 50-60% presence of it along with 
calcium phosphate [11]. Studies have indicated that uric acid, a strong 
endogenous antioxidant, has shown a controversial association with 
bone mineral density [12,13]. Patients with renal insufficiency may 
have reduced bone mineral density due to abnormal concentration 
of vitamin D and parathyroid hormone, and their bone biopsies show 
the evidence for increased bone turnover [14]. Studies have reported 
the association between serum creatinine and skeletal muscle mass 
due to the presence of creatine phosphate in skeletal muscle, of which 
creatinine is primary product [15]. Hence, the assessment of various 
parameters in the progression of osteoporosis may be important to 
know as they play a significant role in other metabolic activities and 
prevent the risk of future development of other diseases.
METHODS
Materials
This study was carried out at the Department of Biochemistry, Santosh 
Medical College & Hospital, Ghaziabad. Total 70 postmenopausal 
women were studied from November 2015 to July 2016. The bone 
mineral density status of the study group was evaluated for diagnosis of 
osteoporosis. Each individual voluntarily participated for being a part 
of the study, and a written consent was taken from them. The fasting 
blood sample was collected from every participant.
Exclusion criteria
Postmenopausal women having diabetes mellitus, hypertension, renal 
disease, thyroid disease, hepatic disorder, secondary osteoporosis, 
smokers, and alcoholics were excluded from the study.
Inclusion criteria
Only postmenopausal women 45-80 years of age without having any 
previous history of bone disease or fracture were included in the 
study.
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Methods
Bone mineral density usually reported as T-score and Z-score. The 
site of examination for measuring T-score and Z-score was at tibia and 
radius. Patients were categorized in two groups, i.e., Case I and Case II 
on the basis of T-score. Case I regard as osteoporosis (>−2.5 standard 
deviation [SD]) while Case II reported as osteopenia (−1 to −2.5 SD), 
in which bone mineral content is lower than normal but greater than 
osteoporosis [16]. Various parameters, i.e., total calcium (CaT) (8.5-
10.5 mg/dl), ionized calcium (CaI) (4.6-5.4 mg/dl), serum inorganic 
phosphate (SPO4) (1.5-6.8 mg/dl), serum ALP (60-170 IU/l), blood urea 
(15-50 mg/dl), serum creatinine (0.6-1.2 mg/dl), serum albumin (3.5-
5 g/dl), serum magnesium (1.9-2.5 mg/dl), and serum uric acid (2.4-
5.7 mg/dl), were investigated in the entire study population.
The estimations of serum CaT and CaI were done by colorimetric 
method [17]. The estimation of SPO4 was done by direct method [18]. 
Serum ALP was done by means of kinetic enzymatic method [19]. 
Serum creatinine estimation was done by Jaffe’s method [20]. Albumin 
measurement was done by bromocresol green method [21]. The 
estimation of blood urea was done by diacetyl monoxime method [22]. 
Serum magnesium was estimated by colorimetric method [23]. Uric 
acid estimation was also done by colorimetric method [24]. The 
institutional ethics committee had given the ethical clearance to 
this study. All procedures performed in studies involving human 
participants were in accordance with the ethical standards of the 
institutional and/or national research committee and with the 1964 
Helsinki declaration and its later amendments or comparable ethical 
standards.
Statistical analysis
All the variables (age, T-score, CaT, CaI, SPO4, ALP, urea, creatinine, 
albumin, Mg, and uric acid) were expressed in mean, standard deviation. 
All the parameters were differentiated between Case I and Case II using 
an unpaired Student’s t-test. The Pearson correlation coefficient was 
applied between the ALP and with other parameters (CaT, CaI, SPO4, 
and uric acid). p<0.05 was considered statistically significant. The 
statistical software IBM SPSS (Statistical Package for Social Sciences) 
Version 20 (Chicago II, USA) was used for statistical analysis.
RESULTS
The mean age of the study population was 59.90 (8.51) years, which 
was non-significant between Case I and Case II (>0.05). T-score in this 
study population (−2.37 [0.74]) was significantly different between the 
groups (−2.86 [0.69] vs. −1.88 [0.38]). The mean values of the CaT level 
and CaI level in aforesaid population were 8.96 (0.94) and 4.48 (0.47), 
respectively. The mean level of CaT and CaI was significantly lower 
in Case I compared to Case II. SPO4 in the study group was higher in 
Case I compared to Case II, which was nonsignificant (>0.05). Serum 
magnesium in total population was significantly (<0.05) different 
between the groups. Serum ALP in the study population was higher in 
Case I compared to Case II and the difference was significant (<0.05). 
Serum concentration of urea (>0.05) was non-significant while the 
concentration of albumin was significant (<0.05) between the groups 
in these postmenopausal women (Fig. 1). Serum creatinine in this study 
was significantly different between Case I and Case II (Fig.2). The mean 
concentration of serum magnesium was significantly different between 
the groups (Fig. 3). Serum Uric acid in this study population was highly 
significant (<0.001) between the groups (Fig. 4), and the level was 
higher in osteoporosis women compared to women having osteopenia 
(Table 1). Serum ALP was negatively correlated with CaT and CaI and 
positively correlated with SPO4 and uric acid. This association was 
significant (<0.05) with CaI (−0.289), CaT (−0.285), SPO4 (0.371), and 
uric acid (0.305) (Table 2).
DISCUSSION
In postmenopausal women, osteoporosis occurs due to estrogen 
deficiency as well as an imbalance between bone resorption 
osteoclastic activity and bone formation osteoblastic activity [25]. 
Swaminathan stated that nutritional factors are essential and needs 
to be corrected in pathogenesis of osteoporosis in support to this 
study. They further concluded that in terms of diet, intake of calcium, 
magnesium, potassium, and vitamin D should be increased and 
intake of salt protein and phosphate should be reduced [26]. In this 
Fig. 2: Presentation of mean concentration of creatinine between 
the groups
Fig. 3: Presentation of mean concentration of magnesium 
between the groups
Fig. 1: Presentation of mean concentration of albumin between 
the groups
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renal complications in women having osteoporosis or osteopenia and 
it may increase with the age [33]. In an animal model-based study, 
osteoporotic rats were characterized by higher concentrations of 
serum creatinine and higher concentration of urea in support to this 
postmenopausal women-based study [34]. The Rancho Bernardo study 
supported this study as they did not find any significant difference in 
albumin concentration between the groups. They further summarized 
that the association between serum albumin and bone mineral density 
was not age dependent [35]. The serum albumin concentration in the 
whole population in this study was supported by Afshinnia et al.’s 
study [36]. The lower concentration of albumin in osteoporosis 
patients was supported by Nilsson et al.’s study [37]. Arpaci et al. 
also supported this study by observing higher concentration of 
albumin in osteopenic women compared to osteoporotic women [38]. 
ALP commonly used as bone mineral marker. It is a ubiquitous 
enzyme and plays an important role in osteoid formation and bone 
mineralization [39]. Jeon et al. observed the higher concentration of 
ALP in postmenopausal women. There was a higher concentration 
of ALP in osteoporotic women compared to osteopenia group [40]. 
Mukaiyama et al. supported these findings by concluding that higher 
bone turnover is a cause for increasing concentration of ALP [41]. 
The inverse correlation of ALP with serum calcium was supported 
by Bhattarai et al.’s study [42]. Fisher and Fisher observed a positive 
association of ALP with SPO4 in older patients with hip fracture 
in support to this study with similar findings [43]. The positive 
association between ALP and uric acid in this study was manifested 
in the postmenopausal women by Sharma et al.’s study [44]. In 
Korean man-based study, it was concluded that serum uric acid 
may act as a protective factor against the development of incident 
of osteoporotic fractures [45]. In postmenopausal women in this 
study, uric acid concentration was significantly higher in osteoporotic 
group compared to osteopenia. Oxidative stress has been found to 
be an important factor in pathogenesis of bone loss due to primary 
osteoporosis [46]. Experimental and epidemiological evidence 
suggested the beneficial effect of uric acid on bone metabolism as an 
antioxidant in postmenopausal women [47]. Lin et al. concluded that 
uric acid is associated with bone mineral density and has a strong 
protective effect at least osteopenia and osteoporosis [48].
CONCLUSIONS
In summary, the outcome of this study reveals the altered concentrations 
of various factors, which cannot be neglected while treating the patients 
having osteoporosis as well as osteopenia, especially in elder population. 
A significant result of serum creatinine highlighted the future prospects 
of developing renal impairment in osteoporotic patients, so monitoring 
is required. The increased concentration of uric acid may develop in the 
form of gout if not considered. Although the sample size of this study 
was small, large population-based study should be conducted to justify 
the fact.
Table 1: Presentation of biochemical parameters between the groups
S. No. Parameters Total (70) Case I (35) Case II (35) p value
Mean±SD Mean±SD Mean±SD
1 Age (years) 59.90±8.51 62.08±10.22 57.71±5.70 0.031
2 T-score −2.37±0.74 −2.86±0.69 −1.88±0.38 0.001
3 Calcium total 8.96±0.94 8.66±1.06 9.26±0.68 0.007
4 Calcium ionized 4.48±0.47 4.33±0.53 4.64±0.34 0.006
5 SPO4 3.96±1.11 4.16±1.21 3.75±0.98 0.127
6 ALP 146.28±34.57 155.31±39.03 137.25±27.11 0.028
7 Urea 38.00±12.61 39.34±13.02 36.65±12.22 0.377
8 Creatinine 1.01±0.19 1.06±0.20 0.97±0.16 0.044
9 Albumin 3.84±0.51 3.98±0.55 3.70±0.42 0.024
10 Magnesium 2.08±0.25 2.02±0.27 2.15±0.22 0.029
11 Uric acid 5.42±1.44 6.13±1.31 4.71±1.21 0.002
Student’s t-test between Case I and Case II. All the data were expressed in mean and SD. p<0.05 was considered statistically significant. SD: Standard deviation, 
ALP: Alkaline phosphatase
Table 2: A correlation between ALP and other parameters
S. No. Parameters R value p value
1 Total calcium −0.285 <0.01
2 CaI −0.289 <0.01
3 S. phosphate 0.305 <0.01
4 Uric acid 0.371 <0.01
By using Pearson correlation coefficient, p<0.01 was considered statistically 
significant. ALP: Alkaline phosphatase
Fig. 4: Presentation of mean concentration of uric acid between 
the groups
study, serum calcium was significantly higher in osteopenia group 
compared to osteoporosis group similar to Roshan et al.’s study based 
on postmenopausal women [27]. SPO4 was higher in postmenopausal 
osteoporotic women compared to osteopenia group. The consistent 
lower concentration of magnesium, from osteopenia to osteoporosis 
in postmenopausal women, was supported by Sharma et al. [28]. 
Magnesium transport system could be affected in osteoporotic 
patients due to the presence of lower concentration of magnesium in 
red blood cells [29]. Mutlu et al. also supported these findings and 
concluded that trace elements supplementation may have beneficial 
effects on the bone mineral density [30]. Monitoring of serum 
creatinine could be helpful in the treatment of patients having low 
bone mineral density [31]. Liang et al. observed in postmenopausal 
women from the Chinese population that serum creatinine was higher 
in osteoporotic group compared to osteopenic group similar to this 
study. They observed negative correlation of serum creatinine with 
bone mineral density [32]. Klawansky et al. observed the significant 
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